Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2Lihong Huang, Jianbo Yue, Guoliang Zhang et al.|Signal Transduction and Targeted Therapy|2021Cited by 51
Berbamine inhibits the infection of SARS-CoV-2 and flaviviruses by compromising TPRMLs-mediated endolysosomal trafficking of viral receptorsLihong Huang, Jianbo Yue, Huanan Li et al.|Research Square (Research Square)|2020Cited by 10